Serial Number | 98240129 |
Word Mark | SHIELDTX |
Filing Date | Wednesday, October 25, 2023 |
Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
Status Date | Tuesday, July 9, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, May 14, 2024 |
Pseudo Mark | SHIELD TX |
Goods and Services | Medical scientific research testing, research and development services in the fields of immune system modeling, antibodies, pharmaceuticals, biologics, immunotherapies, and cell therapies; Drug discovery services; Biotechnology research and development services, namely, providing screening and analysis of immune responses, antibodies, human cells, and pharmaceutical and biologic therapies |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, October 31, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | iBio, Inc |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | New York, NY 10022 |
Party Name | iBio, Inc |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | New York, NY 10022 |
Event Date | Event Description |
Saturday, October 28, 2023 | NEW APPLICATION ENTERED |
Tuesday, October 31, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, March 25, 2024 | ASSIGNED TO EXAMINER |
Monday, April 8, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, May 14, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, May 14, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, July 9, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Wednesday, April 24, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |